Comparison of Two MDS Prognostic Scoring Systems in Patients Undergoing Allogeneic TransplantDaboul, Nour; Gaddam, Mamatha; Berteotti, Gina; Fazal, Salman; Sadashiv, Santhosh; Mewawalla, Prerna; Kaminsky, Anna; Khan, Cyrus; Lister, John · Biology of Blood and Marrow Transplantation · 2018

Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS registerMoreno Berggren, Daniel; Folkvaljon, Yasin; Engvall, Marie; Sundberg, Johan; Lambe, Mats; Antunovic, Petar; Garelius, Hege; Lorenz, Fryderyk; Nilsson, Lars; Rasmussen, Bengt; Lehmann, Sören; Hellström-Lindberg, Eva; Jädersten, Martin; Ejerblad, Elisabeth · British Journal of Haematology · 2018

P-195 Delayed response to lenalidomide in International Prognostic Scoring System (IPSS) low-risk myelodysplastic syndrome (MDS)Garcia, A. Mejia; Asija, A.; Besa, E.C.; Giagounidis, A.; Fonseca, G.A. · Leukemia Research · 2013

Comparative study of the prognostic value for survival and leukemic transformation of three different scoring systems in MDS: Experience of the Spanish cooperative group on MDSG.F. Sanz; T. Vallespi; F. Lopez; D. Irriguible; M.C. Canizo; A. Julia; L. Larrea; C. Sanchez; J.F. San Miguel; M.A. Sanz · 1994

Comparison between the FAB system and three prognostic scoring systems in 245 untreated patients with de novo MDS. The lille experienceP. Morel; M. Hebbar; J.L. Lai; C. Preudhomme; M. Flactif; P. Lepelley; F. Bauters; P. Fenaux · 1994

Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adultsFega, K. Rebecca; Abel, Gregory A.; Motyckova, Gabriela; Sherman, Alexander E.; DeAngelo, Daniel J.; Steensma, David P.; Galinsky, Ilene; Wadleigh, Martha; Stone, Richard M.; Driver, Jane A. · Journal of Geriatric Oncology · 2015

99 CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS)-DEFINED HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS)Garcia-Manero, G.; Savona, M.R.; Gore, S.D.; Cogle, C.R.; Conkling, P.; Hetzer, J.; Dong, Q.; Ukrainskyj, S.M.; Skikne, B.S. · Leukemia Research · 2015

Treatment of patients with high-risk myelodysplastic syndromesNorbert Gattermann; Andrea Kündgen; Ulrich Germing · 2007

No increase in age-specific incidence of myelodysplastic syndromesGerming, Ulrich; Strupp, Corinna; Kü̈ndgen, Andrea; Bowen, David; Aul, Carlo; Haas, Rainer; Gattermann, Norbert · Haematologica · 2004

Novel therapies in low- and high-risk myelodysplastic syndromeGerming, Ulrich; Schroeder, Thomas; Kaivers, Jennifer; Kündgen, Andrea; Kobbe, Guido; Gattermann, Norbert · Expert Review of Hematology · 2019

Causes of death in 2877 patients with myelodysplastic syndromesNachtkamp, Kathrin; Stark, Romina; Strupp, Corinna; Kündgen, Andrea; Giagounidis, Aristoteles; Aul, Carlo; Hildebrandt, Barbara; Haas, Rainer; Gattermann, Norbert; Germing, Ulrich · Annals of Hematology · 2016

Impact on survival of different treatments for myelodysplastic syndromes (MDS)Kathrin Nachtkamp; Andrea Kündgen; Corinna Strupp; Aristoteles Giagounidis; Guido Kobbe; Norbert Gattermann; Rainer Haas; Ulrich Germing · 2009

Diagnosis and Therapy of Myelodysplastic Syndromes in Germany: A Retrospective Multicenter AnalysisGattermann, Norbert; Kündgen, Andrea; Kellermann, Lenka; Zeffel, Matti; Paessens, Bernadette; Germing, Ulrich · Onkologie · 2012

Deep serum discoveries: SDF-1α and HSA fragments in myelodysplastic syndromesFröbel, Julia; Hartwig, Sonja; Jourdain, Sabine; Fischer, Johannes C.; Zilkens, Christoph; Kündgen, Andrea; Suckau, Detlev; Germing, Ulrich; Czibere, Akos; Lehr, Stefan · American Journal of Hematology · 2015